|
|
|
|
Human Resources executive with extensive biopharmaceutical industry experience to lead key employee-related initiatives |
Raleigh, N.C., July 30, 2014 - (ACN Newswire) - INC Research, a leading, global Phase I to IV contract research organization (CRO), today announced it has appointed Jan Schreur as the Company's Senior Vice President, Human Resources. Mr. Schreur brings nearly 30 years of progressive human resources experience to the role, including senior leadership positions at global biopharmaceutical organizations.
"Recruiting, developing and retaining best-in-class talent is essential to our ability to deliver on the needs of our customers," said Chris Gaenzle, Chief Administrative Officer and General Counsel. "Ultimately it is the expertise of our highly-trained professional staff that will fuel our growth. Jan fulfills a pivotal role in ensuring that our employees have the support needed to be successful. His proven track record as a strategic human resources and business leader will be invaluable as INC Research continues to grow our depth of experience and expertise in service to our customers."
Mr. Schreur joins INC Research from Zoetis, the world's largest animal health company, where he served as Vice President, Human Resources. Prior to Zoetis, he served as Vice President, Human Resources at Pfizer where he also supported the spinoff of Pfizer's Animal Health business unit into Zoetis. Mr. Schreur previously held human resources positions of increasing responsibility at Wyeth and Solvay. A native of the Netherlands, he has significant global experience managing human resources issues worldwide. Mr. Schreur holds a HBO (bachelor's degree) in Human Resources Management from the Sociale Academie "Gelderland," and a Post HBO in Human Resources Management from Hogeschool Katholieke Leergangen Tilburg, both in the Netherlands.
With approximately 5,500 employees worldwide, INC Research has the global workforce to support clinical development programs of any size around the world. "INC Research's employees are the Company's single most important asset," said Mr. Schreur. "The Company is committed to creating the best possible employment experience, thereby ensuring its customers have access to experienced, effective teams and innovative thinking to drive delivery of their clinical development projects. I am excited to lead the Human Resources organization that will drive the people and organizational strategies that are such an integral part of our business."
About INC Research
INC Research is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the world's biopharmaceutical and medical device industry. As a therapeutically focused CRO, with a Trusted Process(R) delivery methodology, developing the medicines people need is something we take personally. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market to improve world health. We were ranked "Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, NC, with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research.
LinkedIn: https://www.linkedin.com/company/11776 Twitter: https://twitter.com/inc_research
Contact: Lori Dorer, Media +1-513-345-1685
###
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire
Topic: Executive appointment
Source: INC Research, LLC
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|